Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Geographic Atrophy Market Growth (Status and Outlook) 2022-2028

  • LP 4942162
  • 102 Pages
  • April 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Geographic Atrophy will have significant change from previous year. According to our (LP Information) latest study, the global Geographic Atrophy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Geographic Atrophy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Geographic Atrophy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Geographic Atrophy market, reaching US$ million by the year 2028. As for the Europe Geographic Atrophy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Geographic Atrophy players cover Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, and Hemera Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Above 60 Years

Above 75 Years

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Late-stage (Phase III)

Phase II

Phase I

Pre-clinical stage

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Apellis Pharmaceuticals

Iveric Bio

Alkeus Pharmaceuticals

Hemera Biosciences

Allegro Ophthalmics

Stealth BioTherapeutics

Gyroscope Therapeutics

Regenerative Patch Technologies

Roche

Gensight Biologics

NGM Biopharmaceuticals

AstraZeneca

Lineage Cell Therapeutics

Allergan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Geographic Atrophy Market Size 2017-2028

2.1.2 Geographic Atrophy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Geographic Atrophy Segment by Type

2.2.1 Above 60 Years

2.2.2 Above 75 Years

2.3 Geographic Atrophy Market Size by Type

2.3.1 Geographic Atrophy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Geographic Atrophy Market Size Market Share by Type (2017-2022)

2.4 Geographic Atrophy Segment by Application

2.4.1 Late-stage (Phase III)

2.4.2 Phase II

2.4.3 Phase I

2.4.4 Pre-clinical stage

2.5 Geographic Atrophy Market Size by Application

2.5.1 Geographic Atrophy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Geographic Atrophy Market Size Market Share by Application (2017-2022)

3 Geographic Atrophy Market Size by Player

3.1 Geographic Atrophy Market Size Market Share by Players

3.1.1 Global Geographic Atrophy Revenue by Players (2020-2022)

3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2020-2022)

3.2 Global Geographic Atrophy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Geographic Atrophy by Regions

4.1 Geographic Atrophy Market Size by Regions (2017-2022)

4.2 Americas Geographic Atrophy Market Size Growth (2017-2022)

4.3 APAC Geographic Atrophy Market Size Growth (2017-2022)

4.4 Europe Geographic Atrophy Market Size Growth (2017-2022)

4.5 Middle East & Africa Geographic Atrophy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Geographic Atrophy Market Size by Country (2017-2022)

5.2 Americas Geographic Atrophy Market Size by Type (2017-2022)

5.3 Americas Geographic Atrophy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Geographic Atrophy Market Size by Region (2017-2022)

6.2 APAC Geographic Atrophy Market Size by Type (2017-2022)

6.3 APAC Geographic Atrophy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Geographic Atrophy by Country (2017-2022)

7.2 Europe Geographic Atrophy Market Size by Type (2017-2022)

7.3 Europe Geographic Atrophy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Geographic Atrophy by Region (2017-2022)

8.2 Middle East & Africa Geographic Atrophy Market Size by Type (2017-2022)

8.3 Middle East & Africa Geographic Atrophy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Geographic Atrophy Market Forecast

10.1 Global Geographic Atrophy Forecast by Regions (2023-2028)

10.1.1 Global Geographic Atrophy Forecast by Regions (2023-2028)

10.1.2 Americas Geographic Atrophy Forecast

10.1.3 APAC Geographic Atrophy Forecast

10.1.4 Europe Geographic Atrophy Forecast

10.1.5 Middle East & Africa Geographic Atrophy Forecast

10.2 Americas Geographic Atrophy Forecast by Country (2023-2028)

10.2.1 United States Geographic Atrophy Market Forecast

10.2.2 Canada Geographic Atrophy Market Forecast

10.2.3 Mexico Geographic Atrophy Market Forecast

10.2.4 Brazil Geographic Atrophy Market Forecast

10.3 APAC Geographic Atrophy Forecast by Region (2023-2028)

10.3.1 China Geographic Atrophy Market Forecast

10.3.2 Japan Geographic Atrophy Market Forecast

10.3.3 Korea Geographic Atrophy Market Forecast

10.3.4 Southeast Asia Geographic Atrophy Market Forecast

10.3.5 India Geographic Atrophy Market Forecast

10.3.6 Australia Geographic Atrophy Market Forecast

10.4 Europe Geographic Atrophy Forecast by Country (2023-2028)

10.4.1 Germany Geographic Atrophy Market Forecast

10.4.2 France Geographic Atrophy Market Forecast

10.4.3 UK Geographic Atrophy Market Forecast

10.4.4 Italy Geographic Atrophy Market Forecast

10.4.5 Russia Geographic Atrophy Market Forecast

10.5 Middle East & Africa Geographic Atrophy Forecast by Region (2023-2028)

10.5.1 Egypt Geographic Atrophy Market Forecast

10.5.2 South Africa Geographic Atrophy Market Forecast

10.5.3 Israel Geographic Atrophy Market Forecast

10.5.4 Turkey Geographic Atrophy Market Forecast

10.5.5 GCC Countries Geographic Atrophy Market Forecast

10.6 Global Geographic Atrophy Forecast by Type (2023-2028)

10.7 Global Geographic Atrophy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Apellis Pharmaceuticals

11.1.1 Apellis Pharmaceuticals Company Information

11.1.2 Apellis Pharmaceuticals Geographic Atrophy Product Offered

11.1.3 Apellis Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Apellis Pharmaceuticals Main Business Overview

11.1.5 Apellis Pharmaceuticals Latest Developments

11.2 Iveric Bio

11.2.1 Iveric Bio Company Information

11.2.2 Iveric Bio Geographic Atrophy Product Offered

11.2.3 Iveric Bio Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Iveric Bio Main Business Overview

11.2.5 Iveric Bio Latest Developments

11.3 Alkeus Pharmaceuticals

11.3.1 Alkeus Pharmaceuticals Company Information

11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Product Offered

11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Alkeus Pharmaceuticals Main Business Overview

11.3.5 Alkeus Pharmaceuticals Latest Developments

11.4 Hemera Biosciences

11.4.1 Hemera Biosciences Company Information

11.4.2 Hemera Biosciences Geographic Atrophy Product Offered

11.4.3 Hemera Biosciences Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Hemera Biosciences Main Business Overview

11.4.5 Hemera Biosciences Latest Developments

11.5 Allegro Ophthalmics

11.5.1 Allegro Ophthalmics Company Information

11.5.2 Allegro Ophthalmics Geographic Atrophy Product Offered

11.5.3 Allegro Ophthalmics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Allegro Ophthalmics Main Business Overview

11.5.5 Allegro Ophthalmics Latest Developments

11.6 Stealth BioTherapeutics

11.6.1 Stealth BioTherapeutics Company Information

11.6.2 Stealth BioTherapeutics Geographic Atrophy Product Offered

11.6.3 Stealth BioTherapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Stealth BioTherapeutics Main Business Overview

11.6.5 Stealth BioTherapeutics Latest Developments

11.7 Gyroscope Therapeutics

11.7.1 Gyroscope Therapeutics Company Information

11.7.2 Gyroscope Therapeutics Geographic Atrophy Product Offered

11.7.3 Gyroscope Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Gyroscope Therapeutics Main Business Overview

11.7.5 Gyroscope Therapeutics Latest Developments

11.8 Regenerative Patch Technologies

11.8.1 Regenerative Patch Technologies Company Information

11.8.2 Regenerative Patch Technologies Geographic Atrophy Product Offered

11.8.3 Regenerative Patch Technologies Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Regenerative Patch Technologies Main Business Overview

11.8.5 Regenerative Patch Technologies Latest Developments

11.9 Roche

11.9.1 Roche Company Information

11.9.2 Roche Geographic Atrophy Product Offered

11.9.3 Roche Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Roche Main Business Overview

11.9.5 Roche Latest Developments

11.10 Gensight Biologics

11.10.1 Gensight Biologics Company Information

11.10.2 Gensight Biologics Geographic Atrophy Product Offered

11.10.3 Gensight Biologics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Gensight Biologics Main Business Overview

11.10.5 Gensight Biologics Latest Developments

11.11 NGM Biopharmaceuticals

11.11.1 NGM Biopharmaceuticals Company Information

11.11.2 NGM Biopharmaceuticals Geographic Atrophy Product Offered

11.11.3 NGM Biopharmaceuticals Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 NGM Biopharmaceuticals Main Business Overview

11.11.5 NGM Biopharmaceuticals Latest Developments

11.12 AstraZeneca

11.12.1 AstraZeneca Company Information

11.12.2 AstraZeneca Geographic Atrophy Product Offered

11.12.3 AstraZeneca Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 AstraZeneca Main Business Overview

11.12.5 AstraZeneca Latest Developments

11.13 Lineage Cell Therapeutics

11.13.1 Lineage Cell Therapeutics Company Information

11.13.2 Lineage Cell Therapeutics Geographic Atrophy Product Offered

11.13.3 Lineage Cell Therapeutics Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Lineage Cell Therapeutics Main Business Overview

11.13.5 Lineage Cell Therapeutics Latest Developments

11.14 Allergan

11.14.1 Allergan Company Information

11.14.2 Allergan Geographic Atrophy Product Offered

11.14.3 Allergan Geographic Atrophy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Allergan Main Business Overview

11.14.5 Allergan Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Geographic Atrophy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Above 60 Years

Table 3. Major Players of Above 75 Years

Table 4. Geographic Atrophy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Geographic Atrophy Market Size Market Share by Type (2017-2022)

Table 7. Geographic Atrophy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Geographic Atrophy Market Size Market Share by Application (2017-2022)

Table 10. Global Geographic Atrophy Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Geographic Atrophy Revenue Market Share by Player (2020-2022)

Table 12. Geographic Atrophy Key Players Head office and Products Offered

Table 13. Geographic Atrophy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Geographic Atrophy Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Geographic Atrophy Market Size Market Share by Regions (2017-2022)

Table 18. Americas Geographic Atrophy Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Geographic Atrophy Market Size Market Share by Country (2017-2022)

Table 20. Americas Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Geographic Atrophy Market Size Market Share by Type (2017-2022)

Table 22. Americas Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Geographic Atrophy Market Size Market Share by Application (2017-2022)

Table 24. APAC Geographic Atrophy Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Geographic Atrophy Market Size Market Share by Region (2017-2022)

Table 26. APAC Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Geographic Atrophy Market Size Market Share by Type (2017-2022)

Table 28. APAC Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Geographic Atrophy Market Size Market Share by Application (2017-2022)

Table 30. Europe Geographic Atrophy Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Geographic Atrophy Market Size Market Share by Country (2017-2022)

Table 32. Europe Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Geographic Atrophy Market Size Market Share by Type (2017-2022)

Table 34. Europe Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Geographic Atrophy Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Geographic Atrophy Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Geographic Atrophy Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Geographic Atrophy Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Geographic Atrophy Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Geographic Atrophy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Geographic Atrophy Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Geographic Atrophy

Table 43. Key Market Challenges & Risks of Geographic Atrophy

Table 44. Key Industry Trends of Geographic Atrophy

Table 45. Global Geographic Atrophy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Geographic Atrophy Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Geographic Atrophy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Geographic Atrophy Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Geographic Atrophy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Geographic Atrophy Market Size Market Share Forecast by Application (2023-2028)

Table 51. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 52. Apellis Pharmaceuticals Geographic Atrophy Product Offered

Table 53. Apellis Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Apellis Pharmaceuticals Main Business

Table 55. Apellis Pharmaceuticals Latest Developments

Table 56. Iveric Bio Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 57. Iveric Bio Geographic Atrophy Product Offered

Table 58. Iveric Bio Main Business

Table 59. Iveric Bio Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Iveric Bio Latest Developments

Table 61. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 62. Alkeus Pharmaceuticals Geographic Atrophy Product Offered

Table 63. Alkeus Pharmaceuticals Main Business

Table 64. Alkeus Pharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Alkeus Pharmaceuticals Latest Developments

Table 66. Hemera Biosciences Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 67. Hemera Biosciences Geographic Atrophy Product Offered

Table 68. Hemera Biosciences Main Business

Table 69. Hemera Biosciences Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Hemera Biosciences Latest Developments

Table 71. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 72. Allegro Ophthalmics Geographic Atrophy Product Offered

Table 73. Allegro Ophthalmics Main Business

Table 74. Allegro Ophthalmics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Allegro Ophthalmics Latest Developments

Table 76. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 77. Stealth BioTherapeutics Geographic Atrophy Product Offered

Table 78. Stealth BioTherapeutics Main Business

Table 79. Stealth BioTherapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Stealth BioTherapeutics Latest Developments

Table 81. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 82. Gyroscope Therapeutics Geographic Atrophy Product Offered

Table 83. Gyroscope Therapeutics Main Business

Table 84. Gyroscope Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Gyroscope Therapeutics Latest Developments

Table 86. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 87. Regenerative Patch Technologies Geographic Atrophy Product Offered

Table 88. Regenerative Patch Technologies Main Business

Table 89. Regenerative Patch Technologies Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Regenerative Patch Technologies Latest Developments

Table 91. Roche Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 92. Roche Geographic Atrophy Product Offered

Table 93. Roche Main Business

Table 94. Roche Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Roche Latest Developments

Table 96. Gensight Biologics Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 97. Gensight Biologics Geographic Atrophy Product Offered

Table 98. Gensight Biologics Main Business

Table 99. Gensight Biologics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Gensight Biologics Latest Developments

Table 101. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 102. NGM Biopharmaceuticals Geographic Atrophy Product Offered

Table 103. NGM Biopharmaceuticals Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. NGM Biopharmaceuticals Main Business

Table 105. NGM Biopharmaceuticals Latest Developments

Table 106. AstraZeneca Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 107. AstraZeneca Geographic Atrophy Product Offered

Table 108. AstraZeneca Main Business

Table 109. AstraZeneca Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. AstraZeneca Latest Developments

Table 111. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 112. Lineage Cell Therapeutics Geographic Atrophy Product Offered

Table 113. Lineage Cell Therapeutics Main Business

Table 114. Lineage Cell Therapeutics Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Lineage Cell Therapeutics Latest Developments

Table 116. Allergan Details, Company Type, Geographic Atrophy Area Served and Its Competitors

Table 117. Allergan Geographic Atrophy Product Offered

Table 118. Allergan Main Business

Table 119. Allergan Geographic Atrophy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Allergan Latest Developments

List of Figures

Figure 1. Geographic Atrophy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Geographic Atrophy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Geographic Atrophy Market Size Market Share by Type in 2021

Figure 7. Geographic Atrophy in Late-stage (Phase III)

Figure 8. Global Geographic Atrophy Market: Late-stage (Phase III) (2017-2022) & ($ Millions)

Figure 9. Geographic Atrophy in Phase II

Figure 10. Global Geographic Atrophy Market: Phase II (2017-2022) & ($ Millions)

Figure 11. Geographic Atrophy in Phase I

Figure 12. Global Geographic Atrophy Market: Phase I (2017-2022) & ($ Millions)

Figure 13. Geographic Atrophy in Pre-clinical stage

Figure 14. Global Geographic Atrophy Market: Pre-clinical stage (2017-2022) & ($ Millions)

Figure 15. Global Geographic Atrophy Market Size Market Share by Application in 2021

Figure 16. Global Geographic Atrophy Revenue Market Share by Player in 2021

Figure 17. Global Geographic Atrophy Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Geographic Atrophy Market Size 2017-2022 ($ Millions)

Figure 19. APAC Geographic Atrophy Market Size 2017-2022 ($ Millions)

Figure 20. Europe Geographic Atrophy Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Geographic Atrophy Market Size 2017-2022 ($ Millions)

Figure 22. Americas Geographic Atrophy Value Market Share by Country in 2021

Figure 23. Americas Geographic Atrophy Consumption Market Share by Type in 2021

Figure 24. Americas Geographic Atrophy Market Size Market Share by Application in 2021

Figure 25. United States Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Geographic Atrophy Market Size Market Share by Region in 2021

Figure 30. APAC Geographic Atrophy Market Size Market Share by Application in 2021

Figure 31. China Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Geographic Atrophy Market Size Market Share by Country in 2021

Figure 38. Europe Geographic Atrophy Market Size Market Share by Type in 2021

Figure 39. Europe Geographic Atrophy Market Size Market Share by Application in 2021

Figure 40. Germany Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Geographic Atrophy Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Geographic Atrophy Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Geographic Atrophy Market Size Market Share by Application in 2021

Figure 48. Egypt Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Geographic Atrophy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 54. APAC Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 55. Europe Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 57. United States Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 58. Canada Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 61. China Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 62. Japan Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 63. Korea Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 65. India Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 66. Australia Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 67. Germany Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 68. France Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 69. UK Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 70. Italy Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 71. Russia Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 72. Spain Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 75. Israel Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Geographic Atrophy Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Geographic Atrophy Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390